Abstract
The first 24 hours of a preterm infant’s life is often a period of cardiovascular instability. A complex relationship exists between the heart, brain and systemic and cerebral vasculature and in the immediate neonatal period in which low blood pressure, low systemic blood flow and low cerebral blood flow are common. The preterm infant is at risk of low systemic blood flow (and low blood pressure) due to a combination of intrinsic factors (immaturity of the preterm myocardium and vasculature) as well as extrinsic factors (including mechanical ventilation and vasoactive medications). Low systemic blood flow is common in preterm infants and contributes significantly to the perinatal brain injury, which manifests as peri/intraventricular haemorrhage (P/IVH) and white matter injury. These in turn contribute to the significant neurological and/or developmental disabilities in survivors that impact long term on their quality of life. This paper will look at the evidence currently available for the management of low systemic blood flow in preterm infants.
Keywords: Preterm infant, systemic blood flow, cardiac output
Current Pediatric Reviews
Title:Strategies to Tackle Early Low Flow States in the Extremely Preterm Infant
Volume: 9 Issue: 1
Author(s): Mary Paradisis
Affiliation:
Keywords: Preterm infant, systemic blood flow, cardiac output
Abstract: The first 24 hours of a preterm infant’s life is often a period of cardiovascular instability. A complex relationship exists between the heart, brain and systemic and cerebral vasculature and in the immediate neonatal period in which low blood pressure, low systemic blood flow and low cerebral blood flow are common. The preterm infant is at risk of low systemic blood flow (and low blood pressure) due to a combination of intrinsic factors (immaturity of the preterm myocardium and vasculature) as well as extrinsic factors (including mechanical ventilation and vasoactive medications). Low systemic blood flow is common in preterm infants and contributes significantly to the perinatal brain injury, which manifests as peri/intraventricular haemorrhage (P/IVH) and white matter injury. These in turn contribute to the significant neurological and/or developmental disabilities in survivors that impact long term on their quality of life. This paper will look at the evidence currently available for the management of low systemic blood flow in preterm infants.
Export Options
About this article
Cite this article as:
Paradisis Mary, Strategies to Tackle Early Low Flow States in the Extremely Preterm Infant, Current Pediatric Reviews 2013; 9 (1) . https://dx.doi.org/10.2174/1573396311309010017
DOI https://dx.doi.org/10.2174/1573396311309010017 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypolipidemic, Antioxidant and Cardioprotective Effects of the Aqueous Extract from <i>Scorzanera Undulata</i> Tubers in Streptozotocin-Induced Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry UCLA’s Molecular Screening Shared Resource: Enhancing Small Molecule Discovery with Functional Genomics and New Technology
Combinatorial Chemistry & High Throughput Screening HbA1c, Fructosamine, and Glycated Albumin in the Detection of Dysglycaemic Conditions
Current Diabetes Reviews Matricellular Proteins in Myocardial Infarction
Current Cardiology Reviews Implications of Nanotechnology in Healthcare
Nanoscience & Nanotechnology-Asia Mechanistic Approach to Understanding Psychosis Risk in Velocardiofacial Syndrome
Current Pediatric Reviews Effects of Nicotine on the Cardiovascular System
Vascular Disease Prevention (Discontinued) Oxidative Stress in Atherosclerosis Development: The Central Role of LDL and Oxidative Burst
Endocrine, Metabolic & Immune Disorders - Drug Targets Rho Kinase: An Important Mediator of Atherosclerosis and Vascular Disease
Current Pharmaceutical Design Prostacyclin, Atherothrombosis and Diabetes Mellitus: Physiologic and Clinical Considerations
Current Molecular Medicine Natural Products Towards the Discovery of Potential Future Antithrombotic Drugs
Current Pharmaceutical Design High-Sensitivity C-Reactive Protein and Lipoprotein-Associated Phospholipase A2 in Predicting Recurrence and Severity of Stenosis in Symptomatic Intracranial Atherosclerotic Disease
Current Proteomics Renoprotective Potency of Heme Oxygenase-1 Induction in Rat Renal Ischemia-Reperfusion
Inflammation & Allergy - Drug Targets (Discontinued) MicroRNAs and Ischemic Heart Disease: Towards a Better Comprehension of Pathogenesis, New Diagnostic Tools and New Therapeutic Targets
Recent Patents on Cardiovascular Drug Discovery Nanomedicine: Magnetic Nanoparticles and their Biomedical Applications
Current Medicinal Chemistry Nanobiotechnological Approaches Against Multidrug Resistant Bacterial Pathogens: An Update
Current Drug Metabolism Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness
Current Vascular Pharmacology Pulmonary Hypertension and Lung Transplantation
Current Hypertension Reviews Psychological Stress in Pathogenesis of Essential Hypertension
Current Hypertension Reviews Inflammatory Biomarkers, Depressive Symptoms and Falls Among the elderly in Panama
Current Aging Science